Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
CHEST M.I. is a Japanese respiratory medical device company focused on pulmonary diagnostics and home respiratory care. Founded in 1965, the company develops and markets spirometers, pulmonary function testing systems, forced oscillation technique devices, pulse oximeters, and related accessories and software. Its products are used for evaluation and management of respiratory conditions including asthma and chronic obstructive pulmonary disease, and its business description also includes ventilators, oxygen concentrators, CPAP, and polysomnography in Japan. The company appears to operate as a commercial-stage healthcare company rather than a therapeutic drug developer, with revenue derived from marketed medical devices and respiratory-care products.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on CHEST.